Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
leptin receptor | 0.433 | 0.808 | 0.99 |
|
disease | 0.700 | None | 0.930 | 1 | 1 | 1966 | 2019 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.450 | strong | 1.000 | 1 | 1 | 1976 | 2015 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.919 | 1 | 1 | 1978 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.190 | None | 1.000 | 1 | 1 | 1978 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 1978 | 2015 | ||||||||
|
thyroid peroxidase | 0.455 | 0.846 | 1.8E-21 |
|
disease | 0.200 | None | 0.955 | 3 | 1 | 1979 | 2020 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.430 | None | 1.000 | 1 | 1 | 1979 | 2013 | |||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.200 | None | 0.917 | 1 | 1 | 1979 | 2015 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.130 | None | 1.000 | 2 | 1 | 1980 | 2015 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.200 | None | 0.938 | 1 | 1 | 1980 | 2019 | |||||||||
|
hemoglobin subunit gamma 2 | 0.565 | 0.692 | 0.67 |
|
disease | 0.200 | None | 0.984 | 1 | 1 | 1980 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 1980 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.946 | 1 | 1 | 1980 | 2020 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.500 | None | 0.955 | 1 | 2 | 1980 | 2020 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.700 | None | 0.984 | 1 | 1 | 1980 | 2020 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
group | 0.110 | None | 1.000 | 1 | 1 | 1980 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.700 | None | 0.968 | 2 | 4 | 1981 | 2020 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 0.927 | 8 | 5 | 1982 | 2020 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.700 | None | 0.969 | 3 | 1 | 1982 | 2020 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 1982 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
group | 0.160 | None | 1.000 | 1 | 1 | 1982 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.200 | None | 0.980 | 3 | 1 | 1983 | 2019 | ||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
disease | 0.500 | None | 0.951 | 2 | 2 | 1983 | 2020 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1983 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.410 | None | 1.000 | 1 | 1 | 1983 | 2018 |